Status:
COMPLETED
A Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Neuromuscular Blockade
Neuromuscular Blockade, Residual
Eligibility:
All Genders
80+ years
Phase:
NA
Brief Summary
The number of elderly patients above 80 years is increasing and a large proportion of these patients will require surgery and anesthesia. During anesthesia neuromuscular blocking agents (NMBA) are ad...
Detailed Description
The number of elderly patients (\>80 years) is increasing and a large proportion of these patients will require surgery and anesthesia within the next decades. Elderly patients are at higher risk of m...
Eligibility Criteria
Inclusion
- Age ≥ 80
- Scheduled to elective surgery (expected duration time of surgery \> 1 hour) under general anesthesia with intubation and use of rocuronium.
- American Society of Anesthesiologists (ASA) physical status classification I to III
- Informed consent (see appendix 1)
- Read and understand Danish
Exclusion
- Neuromuscular disease
- Known allergy to rocuronium
- Prone position
- Indication for rapid sequence induction
Key Trial Info
Start Date :
December 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04512313
Start Date
December 17 2020
End Date
May 25 2021
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark